Alector (ALEC) Share-based Compensation (2018 - 2026)
Alector (ALEC) posted quarterly Share-based Compensation of $2.9 million for Q1 2026, down 65.18% year-over-year from $8.4 million in Q1 2025, and down 39.95% quarter-over-quarter from $4.8 million in Q4 2025.
Alector (ALEC) Share-based Compensation (2018 - 2026) Analysis & Trends
Alector (ALEC) has reported Share-based Compensation for 9 consecutive years, with $2.9 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Share-based Compensation fell 65.18% year-over-year to $2.9 million; the TTM figure through Mar 2026 stood at $21.2 million (down 43.44% YoY), while the FY2025 annual figure was $26.7 million, down 32.45% from the prior year.
- Share-based Compensation fell to $2.9 million in Q1 2026 per ALEC's latest filing, from $4.8 million in the prior quarter.
- Across five years, Share-based Compensation topped out at $12.5 million in Q2 2022 and bottomed at $2.9 million in Q1 2026.
- Historically, Share-based Compensation has averaged $9.3 million across 5 years, with a median of $10.2 million in 2024.
- Annual changes were most pronounced in 2022 — Share-based Compensation soared 37.45% — and 2026, when it slumped 65.18%.
- Alector's Share-based Compensation stood at $11.0 million in 2022, then gained by 5.28% to $11.5 million in 2023, then decreased by 11.52% to $10.2 million in 2024, then slumped by 52.58% to $4.8 million in 2025, then tumbled by 39.95% to $2.9 million in 2026.
- Business Quant data shows ALEC's Share-based Compensation at $2.9 million in Q1 2026, $4.8 million in Q4 2025, and $6.4 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | Alector | 218.85 Mn | 46.05 Mn | - | 2.61 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.61 Mn |
| Jun 30, 2026 | 2.61 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Mar 31, 2026 | 2.91 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Dec 31, 2025 | 4.84 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Sep 30, 2025 | 6.40 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Jun 30, 2025 | 7.06 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Mar 31, 2025 | 8.35 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Dec 31, 2024 | 10.21 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Sep 30, 2024 | 9.04 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Jun 30, 2024 | 9.91 Mn |
| Mar 31, 2024 | 10.31 Mn |
| Mar 31, 2024 | 10.31 Mn |